New high-tech version of Realheart's artificial heart
Today Realheart presents the design that is intended to be used during clinical studies in humans. It is a self-regulating heart that is smaller than its predecessor and at the same time has higher pumping capacity.During a press conference at the Technical Museum, Realheart today presented a high-tech version of its artificial heart. After several months of product development, Realheart has come to version 12, which is intended to be used in the clinical trials on humans that are scheduled to start in 2022. As a result of components being downsized, the new version is smaller than its